EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosis

Yang Xu, Adam Korayem, Ana S Cruz-Solbes, Nirupama Chandel, Tomoki Sakata, Renata Mazurek, Spyros A Mavropoulos, Taro Kariya, Tadao Aikawa iD, Kelly P Yamada, Valentina D'Escamard, Bhargavi V'Gangula und 9 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Yang Xu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1014, New York, NY 10029, USA. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Smad3 Protein, Vascular Patency, Neointima. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NHLBI NIH HHS, Haver Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Vein grafts are used for many indications, including bypass graft surgery and arteriovenous fistula (AVF) formation. However, patency following vein grafting or AVF formation is suboptimal for various reasons, including thrombosis, neointimal hyperplasia, and adverse remodelling. Recently, endothelial-to-mesenchymal transition (EndMT) was found to contribute to neointimal hyperplasia in mouse vein grafts. We aimed to evaluate the clinical potential of inhibiting EndMT and developed the first dedicated preclinical model to study the efficacy of local EndMT inhibition immediately prior to AVF creation. Methods and results We first undertook pilot studies to optimize the creation of a femoral AVF in pigs and verify that EndMT contributes to neointimal formation. We then developed a method to achieve local in vivo SMAD3 knockdown by dwelling a lentiviral construct containing SMAD3 shRNA in the femoral vein prior to AVF creation. Next, in Phase 1, six pigs were randomized to SMAD3 knockdown or control lentivirus to evaluate the effectiveness of SMAD3 knockdown and EndMT inhibition 8 days after AVF creation. In Phase 2, 16 pigs were randomized to SMAD3 knockdown or control lentivirus and were evaluated to assess longer-term effects on AVF diameter, patency, and related measures at 30 days after AVF creation. In Phase 1, compared with controls, SMAD3 knockdown achieved a 75% reduction in the proportion of CD31+ endothelial cells co-expressing SMAD3 (P < 0.001) and also a significant reduction in the extent of EndMT (P < 0.05). In Phase 2, compared with controls, SMAD3 knockdown was associated with an increase in the minimum diameter of the venous limb of the AVF (1.56 ± 1.66 vs. 4.26 ± 1.71 mm, P < 0.01) and a reduced degree of stenosis (P < 0.01). Consistent with this, neointimal thickness was reduced in the SMAD3 knockdown group (0.88 ± 0.51 vs. 0.45 ± 0.19 mm, P < 0.05). Furthermore, endothelial integrity (the proportion of luminal cells expressing endothelial markers) was improved in the SMAD3 knockdown group (P < 0.05).

Conclusion

EndMT inhibition in a preclinical AVF model by local SMAD3 knockdown using gene therapy led to reduced neointimal hyperplasia, increased endothelialization, and a reduction in the degree of AVF stenosis. This provides important proof of concept to pursue this approach as a clinical strategy to improve the patency of AVFs and other vein grafts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arteriovenous Shunt, SurgicalSmad3 ProteinVascular PatencyNeointimaDisease Models, AnimalVascular RemodelingAnimalsFemoral VeinPilot ProjectsEndothelial CellsGraft Occlusion, VascularSus scrofaRNA InterferenceTime FactorsEpithelial-Mesenchymal TransitionSignal TransductionFemoral ArteryMale

Stichwörter der Autor:innen

Arteriovenous fistulaEndothelial-to-mesenchymal transitionNeointimaStenosisVein graft

Substanzen

Smad3 Protein

Autor:innen und Institutionen

  • Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1014, New York, NY 10029, USA.
  • Division of Vascular Surgery, Department of Surgery, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
  • Department of Pathology, CARIM, Universiteitssingel 50, Maastricht, The Netherlands.
  • Department of Medicine at Huddinge, Karolinska Institutet, Karolinska Universitetssjukhuset, Stockholm, Sweden.
  • Department of Genetics and Genomic Sciences, Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.

ORCID-Profile: Tadao Aikawa, Manfred Boehm, Jason C Kovacic

Förderung

  • NIH HHS
  • NHLBI NIH HHS
  • Haver Foundation
  • KUHR Consortium
  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Xu, Y., Korayem, A., Cruz-Solbes, A. S., Chandel, N., Sakata, T., Mazurek, R., Mavropoulos, S. A., Kariya, T., Aikawa, T., Yamada, K. P., D'Escamard, V., V'Gangula, B., Baker, A. H., Ma, L., Björkegren, J. L. M., Fuster, V., Boehm, M., Fish, K. M., Tadros, R., …, & Kovacic, J. C. (2024). Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosis. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae157

Vancouver

Xu Y, Korayem A, Cruz-Solbes AS, Chandel N, Sakata T, Mazurek R, et al. Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosis. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae157

BibTeX
@article{Xu2024,
  author = {Xu, Yang and Korayem, Adam and Cruz-Solbes, Ana S and Chandel, Nirupama and Sakata, Tomoki and Mazurek, Renata and Mavropoulos, Spyros A and Kariya, Taro and Aikawa, Tadao and Yamada, Kelly P and D'Escamard, Valentina and V'Gangula, Bhargavi and Baker, Andrew H and Ma, Lijiang and Björkegren, Johan L M and Fuster, Valentin and Boehm, Manfred and Fish, Kenneth M and Tadros, Rami and Ishikawa, Kiyotake and Kovacic, Jason C},
  title = {Inhibition of endothelial-to-mesenchymal transition in a large animal preclinical arteriovenous fistula model leads to improved remodelling and reduced stenosis},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae157}
}
Kostenlos starten →